NCT05337306

Brief Summary

Type 2 Diabetes Mellitus (T2DM) affects over 30 million Americans and requires patients to competently manage their conditions at home. However, the majority of diabetes self-management education (DSME) and aftercare print materials remain overly complicated, with excessively high reading difficulty and fall short in supporting functional readiness for self- management at home, especially for the 18% of U.S. adults unable to read beyond a second-grade level. This project will determine the feasibility of implementing assistive reading technology, designed for patients with limited print or English proficiency, that will immediately expand patient capacity to understand DSME materials, increase T2DM self- management adherence and eventually reduce, at a scale, disparate outcomes in a chronic disease. It will use a small pilot trial design of the GogyUp Reader app to use with print materials versus print materials with no app support and test effects of GogyUp on three-month follow-up measures of health literacy (primary outcome) using the Health Literacy Questionnaire subscales 9 (Understanding health information well enough to know what to do") and 2 ("Having sufficient information to manage my health"); and on three-month follow-up self-reported diabetes management (secondary outcome) using the Perceived Diabetes Self-Management Scale (PDSMS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
193

participants targeted

Target at P75+ for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 20, 2022

Completed
1 year until next milestone

Study Start

First participant enrolled

April 26, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2024

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
6 months until next milestone

Results Posted

Study results publicly available

January 1, 2025

Completed
Last Updated

January 1, 2025

Status Verified

December 1, 2024

Enrollment Period

1.1 years

First QC Date

March 21, 2022

Results QC Date

October 29, 2024

Last Update Submit

December 10, 2024

Conditions

Keywords

adherenceadultaftercarechronic diseasediabetes mellituseducational materialshealth educationLimited English Proficiencypatient educationliteracyhealth literacyassistive technologyhealth disparity

Outcome Measures

Primary Outcomes (2)

  • Health Literacy Questionnaire Subscale 9: Understanding Health Information Well Enough to Know What to do

    The first primary outcome is three-month (follow up) value of the Health Literacy Questionnaire (HLQ) subscale 9: Understanding health information well enough to know what to do The "Understanding health information" subscale is a multi-item, validated subscale of the HLQ and a continuous variable. It is a 5-item subscale, with items scored 1-5 (with higher scores being better) and then mean-aggregated. This study's main objective is to study the effect of GogyUp on health literacy (the ability to use and understand written health information) as a proximal effect of support. The Understanding health information subscale is the most direct measure; three-month follow up reflects (a) brief follow-up in a pilot trial; and (b) this outcome is very proximal to the intervention.

    3 months

  • Health Literacy Questionnaire Subscale 2: Having Sufficient Information to Manage my Health

    The other primary outcome measurement is the three-month (follow up) value of the validated Health Literacy Questionnaire Subscale 2: having sufficient information to manage my health. The "Having sufficient information" subscale is a multi-item, validated subscale of the HLQ and a continuous variable. It is a 4-item subscale, with items scored 1-4 (with higher scores being better) and then mean-aggregated. This study's main objective is to study the effect of GogyUp on health literacy (def: the ability to use and understand written health information) as a most proximal effect of in-the-moment support. As such, the Having sufficient information subscale is an additional direct measure; the three-month time frame reflects (a) a brief follow-up as part of a pilot trial; and (b) is reasonable because of the use of this proximal (to the intervention) outcome based on putative mechanisms.

    3 months

Secondary Outcomes (1)

  • Perceived Diabetes Self-Management Scale Score

    3 months

Study Arms (2)

GogyUp

EXPERIMENTAL

Participants in the GogyUp arm will have the GogyUp Reader app preloaded on a cellular-enabled tablet with the same patient education documents as the Control arm. Patients will be able to use on-demand / in-the-moment assistive-reading technologies to understand any word or phrase: * Speech-to-Text * Word-by-Word Translation * Alternative Formatting * Simplified and Contextualized Definitions * No-Fail Comprehension Questions * Personalized Training in Phonemic Awareness

Other: GogyUp Reader

Control

NO INTERVENTION

Participants in the Standard Care arm will receive the standard after-visit patient education documents the clinics current provide for type 2 diabetes education and self-management.

Interventions

Participants will have unlimited access to the assistive-reading technologies available in the GogyUp Reader app for help understanding post-visit educational documents on type 2 diabetes mellitus disease management.

GogyUp

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of signed and dated informed consent form
  • Males and females; Aged 18-85 years
  • Documented diagnosis of type II diabetes mellitus
  • Has had a visit to a clinic in the past year (April 2020-February 2021); can include a telehealth visit
  • Receives patient education materials and can consent in English

You may not qualify if:

  • Currently enrolled in another treatment or intervention study (at pre-screen)
  • Pregnancy (because pregnancy becomes the primary condition of interest)
  • Note: Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone, internet access) will not be a criterion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MHealth Fairview system

Minneapolis, Minnesota, 55454, United States

Location

Related Links

MeSH Terms

Conditions

Diabetes Mellitus, Type 2BehaviorLiteracyChronic DiseaseDiabetes MellitusHealth Education

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesCommunicationDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Results Point of Contact

Title
Ned Zimmerman-Bence, Co-Founder
Organization
GogyUp

Study Officials

  • Ned Zimmerman-Bence

    GogyUp Inc

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2022

First Posted

April 20, 2022

Study Start

April 26, 2023

Primary Completion

June 12, 2024

Study Completion

June 30, 2024

Last Updated

January 1, 2025

Results First Posted

January 1, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Dr. Shippee (having led analyses) will submit summary results to ClinicalTrials.gov following timeline completion of the analyses concurrent with manuscript results preparation, which should be within two to three months post follow-up for final participants.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Study data will be available once final report has been accepted by the National Institute for Nursing Research (the funding agency). Analytic date will remain available through the University of Minnesota's Clinical Data Repository managed by the University of Minnesota's Clinical and Translational Sciences Institute.
Access Criteria
Criteria include employees of federal agencies or institutions of higher learning.

Locations